Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
INFI > SEC Filings for INFI > Form 8-K on 25-Sep-2013All Recent SEC Filings

Show all filings for INFINITY PHARMACEUTICALS, INC. | Request a Trial to NEW EDGAR Online Pro

Form 8-K for INFINITY PHARMACEUTICALS, INC.


25-Sep-2013

Other Events, Financial Statements and Exhibits


Item 8.01. Other Events

On September 25, 2013 we issued a press release announcing topline data from our Phase 2 study of retaspimycin hydrochloride in combination with docetaxel in patients with non-small cell lung cancer. A copy of this press release is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.



Item 9.01. Financial Statements and Exhibits

(d) The following exhibit is included in this report:

Exhibit
  No.                                     Description

99.1         Press release dated September 25, 2013, entitled Infinity Reports
             Topline Data from Phase 2 Study of Retaspimycin Hydrochloride, its
             Hsp90 Inhibitor, in Patients with Non-Small Cell Lung Cancer.


  Add INFI to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for INFI - All Recent SEC Filings
Sign Up for a Free Trial to the NEW EDGAR Online Pro
Detailed SEC, Financial, Ownership and Offering Data on over 12,000 U.S. Public Companies.
Actionable and easy-to-use with searching, alerting, downloading and more.
Request a Trial      Sign Up Now


Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.